• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment.

作者信息

Costanza Marco B, Reynolds Kelly A, Mervak Julie E

机构信息

University of Michigan Medical School, Ann Arbor, Michigan.

Department of Dermatology, University of Michigan, Ann Arbor, Michigan.

出版信息

JAAD Case Rep. 2023 Jun 15;38:61-63. doi: 10.1016/j.jdcr.2023.06.006. eCollection 2023 Aug.

DOI:10.1016/j.jdcr.2023.06.006
PMID:37600732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10433323/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/4abf23541148/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/425aba230f3e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/42132a74dc4b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/50ddc4675c65/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/4abf23541148/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/425aba230f3e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/42132a74dc4b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/50ddc4675c65/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/10433323/4abf23541148/gr4.jpg

相似文献

1
Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment.使用阿达木单抗和2%托法替布软膏治疗难治性血管狼疮样结节病
JAAD Case Rep. 2023 Jun 15;38:61-63. doi: 10.1016/j.jdcr.2023.06.006. eCollection 2023 Aug.
2
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy.用2%托法替布软膏和脉冲染料激光疗法治疗血管性狼疮样结节病。
JAAD Case Rep. 2020 Dec 1;7:122-124. doi: 10.1016/j.jdcr.2020.11.016. eCollection 2021 Jan.
3
Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil.用2%托法替布软膏和特级初榨橄榄油治疗皮肤结节病。
JAAD Case Rep. 2020 Dec 25;9:1-3. doi: 10.1016/j.jdcr.2020.12.021. eCollection 2021 Mar.
4
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.Janus 激酶抑制可诱导皮肤结节病和环状肉芽肿缓解。
J Am Acad Dermatol. 2020 Mar;82(3):612-621. doi: 10.1016/j.jaad.2019.05.098. Epub 2019 Jun 8.
5
Cutaneous sarcoidosis in southern Taiwan: clinicopathologic study of a series with high proportions of lesions confined to the face and angiolupoid variant.台湾南部的皮肤结节病：一系列以局限于面部和血管样变型病变比例高为特征的临床病理研究。
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):499-505. doi: 10.1111/j.1468-3083.2012.04473.x. Epub 2012 Feb 20.
6
Treatment of Multiorgan Sarcoidosis With Tofacitinib.托法替布治疗多器官结节病
ACR Open Rheumatol. 2020 Feb;2(2):106-109. doi: 10.1002/acr2.11112. Epub 2020 Jan 9.
7
Disseminated angiolupoid sarcoidosis.播散性血管狼疮样结节病。
Cutis. 1987 Oct;40(4):341-3.
8
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis.托法替布治疗皮肤结节病：一例病例报告及结节病中 Janus 激酶抑制作用的证据综述
JAAD Case Rep. 2021 Aug 20;16:62-64. doi: 10.1016/j.jdcr.2021.08.012. eCollection 2021 Oct.
9
Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab--a paradoxical effect? A case report.阿达木单抗加重顽固性皮肤结节病——一种矛盾的效应？病例报告。
An Bras Dermatol. 2013 Nov-Dec;88(6 Suppl 1):26-8. doi: 10.1590/abd1806-4841.20132487.
10
Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.肿瘤坏死因子-α抑制剂阿达木单抗对难治性结节病患者的疗效：一项使用氟代脱氧葡萄糖正电子发射断层扫描的前瞻性观察研究
Clin Respir J. 2012 Oct;6(4):238-47. doi: 10.1111/j.1752-699X.2011.00276.x. Epub 2012 Feb 13.

本文引用的文献

1
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy.用2%托法替布软膏和脉冲染料激光疗法治疗血管性狼疮样结节病。
JAAD Case Rep. 2020 Dec 1;7:122-124. doi: 10.1016/j.jdcr.2020.11.016. eCollection 2021 Jan.
2
Sarcoidosis.结节病。
Nat Rev Dis Primers. 2019 Jul 4;5(1):45. doi: 10.1038/s41572-019-0096-x.
3
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.托法替尼治疗与皮肤结节病的分子分析。
N Engl J Med. 2018 Dec 27;379(26):2540-2546. doi: 10.1056/NEJMoa1805958.
4
Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety.抗肿坏死因子制剂治疗结节病：疗效和安全性的系统评价。
Semin Arthritis Rheum. 2019 Jun;48(6):1093-1104. doi: 10.1016/j.semarthrit.2018.10.005. Epub 2018 Oct 16.
5
A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis.阿达木单抗治疗皮肤结节病的双盲、随机、安慰剂对照试验。
J Am Acad Dermatol. 2013 May;68(5):765-73. doi: 10.1016/j.jaad.2012.10.056. Epub 2012 Dec 28.
6
Cutaneous sarcoidosis in southern Taiwan: clinicopathologic study of a series with high proportions of lesions confined to the face and angiolupoid variant.台湾南部的皮肤结节病：一系列以局限于面部和血管样变型病变比例高为特征的临床病理研究。
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):499-505. doi: 10.1111/j.1468-3083.2012.04473.x. Epub 2012 Feb 20.
7
A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department.皮肤科评估的 34 例皮肤结节病患者的回顾性分析。
Clin Exp Dermatol. 2010 Mar;35(2):131-4. doi: 10.1111/j.1365-2230.2009.03400.x. Epub 2009 Jul 6.
8
Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?类固醇抵抗性结节病：肿瘤坏死因子-α拮抗作用是答案吗？
Clin Sci (Lond). 2007 Mar;112(5):281-9. doi: 10.1042/CS20060094.
9
Adalimumab for treatment of cutaneous sarcoidosis.阿达木单抗用于治疗皮肤结节病。
Arch Dermatol. 2006 Jan;142(1):17-9. doi: 10.1001/archderm.142.1.17.